Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Multiple sclerosis (MS) is one of the most widespread ... remitting MS. Other types include primary progressive MS, secondary progressive MS, and clinically isolated MS. Contact your doctor ...

can slow the progression of the disease in primary progressive multiple sclerosis, and syponimod (Mayzent) can help with secondary progressive multiple sclerosis. There’s currently no specific ...

The following is a summary of “Neurofilament heavy chain in secondary progressive multiple sclerosis,” published in the January 2025 issue of Neurology by Angelis et al. Biomarkers are essential for ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Actor and advocate Selma Blair joins TODAY to discuss her work for people with multiple sclerosis after sharing her diagnosis ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...